4-Desmethyl 7-Prenyl Mollicellin Analogue Isolated from <i>Chaetomium brasiliense</i>

A new depsidone, termed mollicellin Z2 (1), and three known mollicellins D, H, and I (2-4), were isolated from cultured Chaetomium brasiliense NBRC 6548 mycelia. The structure of 1 was determined from one dimensional (1D) and 2D-NMR and high resolution electron ionization (HREI)MS spectra. It is the first 4-desmethyl mollicellin analogue found to contain a C-7 prenyl group and is likely generated via a biosynthetic pathway that is distinct from those that produce the 27 known analogues. This is the first report of mollicellin derivatives with antibacterial activity against nontuberculous mycobacteria.

Authors

Institutions

Publication Details

Journal
Chemical and Pharmaceutical Bulletin
Published
2026-02-12
DOI
https://doi.org/10.1248/cpb.c25-00729
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

4-Desmethyl 7-Prenyl Mollicellin Analogue Isolated from Chaetomium brasiliense

Aki Hirabayashi, Sho Furumura, Teigo ASAI, Taro Ozaki et al.
Chemical and Pharmaceutical Bulletin
Microbial Natural Products and Biosynthesis
article

4-Desmethyl 7-Prenyl Mollicellin Analogue Isolated from Chaetomium brasiliense

Aki Hirabayashi, Sho Furumura, Teigo ASAI, Taro Ozaki, Y. Oshima, Yoshihiko Hoshino, Yohei Morishita, Hanako Fukano, Masato Suzuki, Shuntaro Morita
article en

Abstract

A new depsidone, termed mollicellin Z2 (1), and three known mollicellins D, H, and I (2-4), were isolated from cultured Chaetomium brasiliense NBRC 6548 mycelia. The structure of 1 was determined from one dimensional (1D) and 2D-NMR and high resolution electron ionization (HREI)MS spectra. It is the first 4-desmethyl mollicellin analogue found to contain a C-7 prenyl group and is likely generated via a biosynthetic pathway that is distinct from those that produce the 27 known analogues. This is the first report of mollicellin derivatives with antibacterial activity against nontuberculous mycobacteria.

Chemical and Pharmaceutical BulletinVol. 74(2)
Tohoku University (JP), National Institute of Infectious Diseases (JP), Tohoku Medical and Pharmaceutical University (JP)
Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency, Core Research for Evolutional Science and Technology, Advanced Low Carbon Technology Research and Development Program
Openalex Percentile: Top 57%
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.